Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Clin Pharmacol Ther1
Search Results
Sort by
- BookHenrik Hellquist, Alena Skalova.Summary: Over the past 25 years it has become more and more evident that salivary gland pathology is by far the subject within head and neck pathology that causes the most diagnostic challenges and problems for general pathologists. Among the reasons for this are the relative rarity of salivary gland tumors (as a result of which the general pathologist does not gain sufficient personal experience in their diagnosis), their striking diversity (there are almost 40 different histological tumor entities), and the fact that some tumours dedifferentiate and some benign tumors progress to become malignant. This book is a comprehensive guide to salivary gland pathology that illustrates almost every type of salivary gland tumor and will assist greatly in routine diagnostic work. Non-neoplastic lesions, benign epithelial tumors, malignant epithelial tumors, and non-epithelial and secondary tumors are all covered in detail, and the WHO and TNM classifications are clearly explained. Another significant feature is the incorporation of important knowledge gained during the past few years regarding the genetics of salivary gland tumors. Histopathology of the Salivary Glands will be of interest not only to pathologists but also to dentists, ENT and head and neck surgeons, and oncologists.
Contents:
Histology
Non-neoplastic Lesions
Pleomorphic Adenoma
Myoepithelioma
Warthin Tumour
Other Adenomas
Mucoepidermoid Carcinoma
Adenoid Cystic Carcinoma
Acinic Cell Carcinoma
Carcinoma Ex Pleomorphic Adenoma
Salivary Duct Carcinoma
Polymorphous Low-Grade Adenocarcinoma
Myoepithelial Carcinoma and Epithelial-Myoepithelial Carcinoma
Mammary Analogue Secretory Carcinoma (MASC)
Other Carcinomas
Miscellaneous. - ArticleFrisk-Holmberg M, Bergkvist Y, Domeij-Nyberg B, Hellström L, Jansson F.Clin Pharmacol Ther. 1979 Mar;25(3):345-50.Serum concentrations of chloroquine were determined fluorometrically in 100 rheumatoid patients who had been treated with 0.25 gm daily for at least 2 mo. The total dose varied between 3.7 and 400 gm. No patient received more than 75 gm annually. In 15% of the patients side effects were noted. There was a relationship between serum concentrations and side effects but not with the total dose administered. Chloroquine displayed dose-dependent kinetics, which may indicate that close monitoring of serum concentrations is an aid to the safe and rational use of the drug.